Description

Overview of CJC‑1295

CJC‑1295 is a modified growth hormone‑releasing hormone (GHRH) analog engineered for extended half‑life, enabling sustained GH secretion with less frequent dosing. This peptide has become a vital tool in research on GH deficiency, tissue regeneration, metabolic regulation, and aging.

Growth Hormone Deficiency and Aging

As GH production wanes with age or pituitary impairment, CJC‑1295 can recreate a more youthful GH profile. Preclinical studies examine its ability to improve muscle mass, bone density, and skin health, potentially mitigating age‑related declines in physical function and quality of life.

Muscle Growth and Fat Loss

GH is a key driver of anabolic processes and lipolysis. Researchers use CJC‑1295 to study lean‑mass accrual, enhanced protein synthesis, and fat‑burn pathways, comparing its efficacy and safety against conventional anabolic agents.

Obesity and Metabolic Disorders

By improving lipid metabolism and insulin sensitivity, CJC‑1295 shows promise as a research tool for tackling visceral adiposity, dyslipidemia, and type 2 diabetes. Ongoing work investigates changes in adipokine profiles, glucose homeostasis, and inflammatory markers.

Recovery and Injury Repair

GH stimulates collagen production and tissue regeneration. Studies employing CJC‑1295 explore accelerated healing in musculoskeletal injuries, enhanced cartilage repair, and recovery protocols in preclinical injury models.

Neuroprotection and Cognitive Health

Emerging data suggest GH influences neuroplasticity and cognitive resilience. Early‐stage research is probing whether CJC‑1295–induced GH spikes can protect neurons, enhance synaptic function, and slow cognitive decline in models of aging and neurodegeneration.

Anti‑Aging Therapies

Beyond its metabolic effects, GH may support skin elasticity and cellular renewal. Researchers are evaluating CJC‑1295 as part of combination regimens aimed at promoting overall vitality, tissue turnover, and visible markers of aging in vitro and in vivo.

Cancer Research (Hormonal Regulation)

Given GH’s role in cell proliferation, CJC‑1295 is also used to study tumor biology and hormonal interactions. These investigations aim to clarify GH’s impact on oncogenic pathways, aiding in the design of safer GH‑modulating therapies for at‑risk populations.

Combination with Other Peptides and Therapies

Synergistic protocols pairing CJC‑1295 with peptides like Ipamorelin are under scrutiny for optimized GH pulsatility, enhanced fat loss, and recovery acceleration. These combination studies inform dosing strategies and mechanistic insights for translational research.

Key Specifications

• Purity: ≥98% by HPLC

• Formulation: Lyophilized white powder

• Dosage: 2 mg per vial

• Storage: –20 °C; protect from moisture and light

Research Use Only